Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Orthop. Jan 18, 2020; 11(1): 36-46
Published online Jan 18, 2020. doi: 10.5312/wjo.v11.i1.36
Table 7 Characteristics of all patients with positive alpha-defensin lateral flow test and/or positive or inconclusive criteria
CaseCriteria
A
B
C
D
E
F
G
H
I
PJI?
ArtSinus tractVisible purulenceCRP (mg/ L)ESR (mm/h)WBC count (cells/μL)PMN%Culture synovial fluid (nr of cultures)Culture tissue (nr of cultures)ADMSIS (+/-; criteria)EBJIS (+/-; criteria)2018 ICM (+/-/i; criteria)Revision surgery1- or 2-stage
1CoC--6.521.01910091neg (1)neg (6)+-E,F+E,F+E,F,IYes2-stage
2MoPYes-9.023.0--pos (2)pos (8/9)++A,G,H+A,G,H+A,G,H,IYes2-stage
3MoP--8.529.030004neg (2)---+E-No-
4MoP--9.816.0620077neg (2)pos (5/8)++E,H+E,F,H+E,H,IYes2-stage
5CoC--6.910.02300-neg (1)---+E-No-
6MoP--12.026.010-neg (2)pos (1/2)--C,H-iC,HYes1-stage
7MoP----9350-neg (1)---E+E-ENo-
8HA------neg (1)pos (1/6)+-H-iH,IYes1-stage
9MoP--144.064.03730092pos (1/2)pos (2/6)++C,D,E,F,G,H+E,F,G,H+C,D,E,F,H,IYesDAIR
10MoP--61.072.0790095pos (1/1)pos (9/9)++C,D,E,F,G,H+E,F,G,H+C,D,E,F,H,IYes2-stage
11MoP--71.055.03530097pos (2/2)pos (7/7)++C,D,E,F,G,H+E,F,G,H+C,D,E,F,H,IYes2-stage
12HA--9.6-490081--+-E,F+E,F+E,F,INo-
13MoM-Yes195.0-26400096neg (2)-++B,C,E,F+B,E,F+B,C,E,F,INo-
14MoP--15.013.08000-neg (1)neg (6)+-C,E+E+C,E,IYes2-stage
15HA--1.09.0400015neg (2)---E+E-ENo-
16MoM--5.78.0517052neg (3)-+-E+E+E,INo-